It is well established that macrophages (M-phi) play a key role in the induction and maintenance of neovascularization during normal wound repair and are responsible in part for the aberrant endothelial proliferation that occurs in certain chronic inflammatory diseases such as psoriasis and neovascularization of solid tumors. More recently we have reported that activated M-phi produce the potent angiogenesis inhibitor thrombospondin-1 (TSP1). Although this observation would seem paradoxical we now have evidence that both murine and human monocyte- derived M~ undergo a """"""""transition"""""""" from a potent proangiogenic to an equally potent angiostatic, TSP1 producing, phenotype. This would imply that M-phi can coordinate wound neovascularization. The hypothesis underlying the proposed work is that during normal wound repair M-phi function as both proangiogenic and angiostatic effector cells. The """"""""transition"""""""" from the proangiogenic to the angiostatic phenotype parallels the expression pattern of the angiogenesis inhibitor TSP1. We further hypothesize that when Mphi fail to undergo this """"""""transition"""""""" as in the chronic inflammatory skin disease psoriasis and during the development of solid tumors, this contributes significantly to the aberrant endothelial cell proliferation and neovascularization that is characteristic of these disorders.
The specific aims of this proposal are: 1. To determine if macrophages (M-phi) during normal in vivo wound repair, (a) undergo a """"""""transition"""""""" from a proangiogenic to an angiostatic phenotype, (b) if this event parallels the expression pattern of the angiostatic glycoprotein TSP1 and (c) if this transition enables Mphi to regulate wound neovascularization. 2. To examine the proangiogenic and angiostatic potential of wound- derived M-phi from TSP1 knockout mice. 3. To determine if psoriatic dermal endothelial cell proliferation and neovascularization of solid tumors are due in part to a failure of M-phi to undergo this """"""""transition"""""""" from a proangiogenic to an angiostatic, TSP1 producing, phenotype. The studies proposed in this application should reveal new insights into the mechanism that coordinate the timely ingrowth and regression of new capillaries during wound repair, increase our understanding of the mechanism underlying the disregulated endothelial cell proliferation and neovascularization that occurs in psoriasis and solid tumor formation, and suggest novel strategies for the treatment of these and other angiogenesis/vasoproliferative-dependent disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039926-12
Application #
2714006
Study Section
Pathology A Study Section (PTHA)
Project Start
1988-02-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
2000-05-31
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Polverini, Peter J; Nor, Jacques E; Peters, Martin C et al. (2003) Growth of human blood vessels in severe combined immunodeficient mice. A new in vivo model system of angiogenesis. Methods Mol Med 78:161-77
Lane, Brian R; Liu, Jianguo; Bock, Paul J et al. (2002) Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. J Virol 76:11570-83
Nor, J E; Peters, M C; Christensen, J B et al. (2001) Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 81:453-63
Nor, J E; Mitra, R S; Sutorik, M M et al. (2000) Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 37:209-18
Nor, J E; Christensen, J; Mooney, D J et al. (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154:375-84
Polverini, P J; Nor, J E (1999) Apoptosis and predisposition to oral cancer. Crit Rev Oral Biol Med 10:139-52
Nissen, N N; Polverini, P J; Koch, A E et al. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-52
Polverini, P J (1997) Role of the macrophage in angiogenesis-dependent diseases. EXS 79:11-28
Castle, V P; Dixit, V M; Polverini, P J (1997) Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Lab Invest 77:51-61
Hsu, S C; Volpert, O V; Steck, P A et al. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56:5684-91

Showing the most recent 10 out of 35 publications